Skip to main content
Premium Trial:

Request an Annual Quote

Hong Kong Dx Firm Prenetics Shares Down 9 Percent on First Day on Nasdaq

NEW YORK – Genomics and diagnostics company Prenetics ended its first day as a publicly traded company on the Nasdaq on Wednesday with its stock down 9 percent.

In early morning trading Thursday, shares of the company continued to fall as its stock price was down 29 percent to $5.41.

The Hong Kong-based firm began trading on the Nasdaq after announcing its merger with Artisan Acquisition in September. At the time Prenetics was valued at $1.25 billion with a combined equity value of $1.7 billion, and it said it was the first Hong Kong-based unicorn to be publicly listed in any market. Under the deal, Prenetics said it would receive up to $459 million in cash, including up to $339 million held in Artisan's trust and forward purchase agreements of $120 million.

Earlier this month, the company reported that its Q1 revenues increased 60 percent year over year to $92.0 million, driven by demand for its diagnostics and genetic testing services.

Prenetics currently offers its Circle HealthPod point-of-care and at-home rapid detection system for infectious diseases, which received CE marking in August. The firm also offers whole-exome sequencing directly to consumers via its CircleDNA brand.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.